CPHI Stock Analysis: Buy, Sell, or Hold?

CPHI - China Pharma Holdings, Inc.

PHARMACEUTICAL PREPARATIONS
$0.95
-0.03 (-3.06%) β–Ό
5d: -12.04%
30d: -37.5%
90d: +25.05%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 13, 2026 0d

Get Alerted When CPHI Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CPHI is down 12.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
See Forward Earnings Fair Value & Price Prediction β†’

In-depth Analysis How we analyze

Valuation Analysis: CPHI is currently trading at $0.95, which is considered fair relative to its 30-day fair value range of $0.14 to $2.74.

Technical Outlook: Technically, CPHI is showing sideways momentum. The price is currently testing key support at $0.96. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.1% recently.

Market Sentiment: CPHI scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $3.00 (+206.1%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $0.14 - $2.74
Company Quality Score 52/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 81.6%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-3.1%)
  • BULLISH: Trading 206.1% below Wall St target ($3.00)
  • WARNING: Composite score 52/100 in the bottom quintile β€” this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $0.14 - $2.74
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $0.96
Resistance Level $1.23
Current Trend Sideways
Technical data as of Aug 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) 1.56
Wall Street Target $3.00 (+206.1%)
Revenue Growth (YoY) -7.5%
Profit Margin -114.3%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 24, 2026 12:57 PM ET
Data refreshes hourly during market hours. Next update: 1:57 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NBIX
Neurocrine Biosciences I…
STRONG BUY
25 analysts
$212 67 BUY
LNTH
Lantheus Holdings Inc
STRONG BUY
13 analysts
$107 56 HOLD
ZTS
Zoetis Inc
BUY
20 analysts
$101 43 HOLD
UTHR
United Therapeutics Corp…
STRONG BUY
15 analysts
$664 48 HOLD
LQDA
Liquidia Technologies Inc
STRONG BUY
10 analysts
$108 55 HOLD

More Analysis for CPHI

CPHI Technical Chart CPHI Price Prediction CPHI Earnings Date CPHI Investment Advisor CPHI Fair Price Analyzer CPHI Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals